February 19, 2025
Hikma Pharmaceuticals USA Inc., et al., Petitioners v. Amarin Pharma, Inc., et al.
Case Number:
24-889
Court:
Nature of Suit:
830 Patent Infringement (Fed. Qst.)
Firms
- Barnes & Thornburg
- Covington & Burling
- Dinsmore & Shohl
- Foley Hoag
- Goodwin Procter
- Jenner & Block
- Jones Day
- Massey & Gail
- McDonnell Boehnen
- Orrick Herrington
- Perkins Coie
- Upadhye Tang
- Weil Gotshal
- Winston & Strawn
- Zuckerman Spaeder
Companies
- AbbVie Inc.
- American Intellectual Property Law Association
- Association for Accessible Medicines
- Hikma Pharmaceuticals PLC
- Intellectual Property Owners Association
- Pharmaceutical Research & Manufacturers of America
- Public Citizen Inc.
- Regeneron Pharmaceuticals Inc.
- Sanofi
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 30, 2026
Don't Set Special IP Rules For 'Skinny Labels,' Justices Told
Drugmakers, industry groups, hospitals and scholars have urged the U.S. Supreme Court to uphold a decision letting a patent suit proceed over a generic drug using a so-called skinny label, saying the generics company is seeking unwarranted special protections that would upend patent law.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login